Various medication shortages have occurred over the past 7 years, according todata from the Center for Drug Evaluation and Research.
"We estimate there are several hundred unapproved drugs out there, " said Deborah Autor, director of the office of compliance within the FDA's Center for Drug Evaluation and Research.
The most likely explanation: the leadership of the division of the FDA responsible for drug regulation, the Center for Drug Evaluation and Research (CDER), is seeking to avoid accountability for its role in the Avandia tragedy.
FORBES: Steven Nissen: The Hidden Agenda Behind The FDA's New Avandia Hearings
"Until today, patients with diabetes who need insulin to manage their disease had only one way to treat their condition, " said Dr. Steven Galson, Director, Center for Drug Evaluation and Research, FDA, in a prepared statement.
"Kadcyla delivers the drug to the cancer site to shrink the tumor, slow disease progression and prolong survival, " said Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research, in a statement.
"We want healthcare professionals and patients to have the most current information on the risks of statins, but also to assure them that these medications continue to provide an important health benefit of lowering cholesterol, " said Dr. Mary Parks, in the FDA's Center for Drug Evaluation and Research.
Moreover, the lorcaserin carcinogenicity studies were also thoroughly reviewed and discussed by the Center for Drug Evaluation and Research (CDER) Executive Carcinogenicity Assessment Committee, and the results of this scientific assessment were included in the background documents provided to the committee and discussed in Agency presentations at the Advisory Committee meeting.
In a letter sent to the head of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, Wolfe outlined a statistical analysis he had done of a 1999 Pfizer-funded test of Celebrex as a preventative for Alzheimer's disease that had just been made available on an industry Web site of clinical trial results.
"Be on the lookout for any esophageal symptoms if you take oral bisphosphonates, especially swallowing difficulty and throat, chest, or digestive discomfort, and report them to your physician for prompt evaluation and drug discontinuation, " she says.
After post-approval evaluation, the drug was withdrawn in June 2010 as ineffective.
CNN: Are there any treatments for acute myelogenous leukemia?
Adverse event reporting has a critical role in the evaluation of the safety of a drug or medical device during its testing.
The two companies filed a New Drug Application on Jan. 9, 2009 and learned in November that the agency extended the review date of Horizant to Feb. 9 to perform a risk evaluation and mitigation plan for the drug.
But Neil McKeganey, director of Glasgow University's drug-misuse research centre, says that despite all the money and effort put into drug treatment schemes, there has been little serious evaluation of them.
The FDA will also ask the panel to evaluate a proposed Risk Evaluation and Mitigation Strategies (REMS) if the drug gains approval.
The Visudyne dye, which is manufactured by drug company CIBA UK, was approved by the European Medicines Evaluation Agency four weeks ago after being tested in two 12-month clinical trials.
Bayer said in a statement that it "mistakenly" did not tell the FDA about the evaluation of 67, 000 hospital records regarding the drug Trasylol, which is used to prevent bleeding during open-heart surgery.
Bayer (nyse: BAY - news - people ) said in a statement that it "mistakenly" did not tell the FDA about the evaluation of 67, 000 hospital records regarding the drug Trasylol, which is used to prevent bleeding during open-heart surgery.
We also released two reports, one from the Office of the Assistant Secretary for Planning and Evaluation (ASPE) that asses the underlying factors that lead to drug shortages and an FDA report on their role in monitoring, preventing, and responding to these shortages.
Once a drug went into trials the emphasis was on moving it through, often without enough critical evaluation of whether the compound had what it takes.
"It's not any different from what we knew back in February, " says Eric Holmboe , a vice president for evaluation research at the American Board of Internal Medicine who served on the Food and Drug Administration panel that looked at the risks of common pain drugs.
应用推荐